Protective effect of Ulinastatin on the ischemia-reperfusion injury of pancreas in rats
Chen Yuanyan
Abstract
Chen Yuanyan
Abstract
Objective To study the protective effect of Ulinastatin on ischemia-reperfusion injury of pancreas in rats and assess the possible mechanism.Methods Seventy-two SD rats were randomly divided into pseudoperation group,ischemia-reperfusion group and Ulinastatin group.During the pancreatic ischemia for 30 minutes and reperfusion in 0,6,12 and 24 hours,serum TNF-α and IL-1β were determined with enzyme linked immunosorbent assay(ELISA);expression of bcl-2,HSP70 in pancreas cells were studied with immunohistochemical methods and pancreas histopathology was observed,respectively.Results The expression level of TNF-α and IL-1β in ischemia-reperfusion group was obviously higher than those in pseudoperation group and Ulinastatin group(P0.05);The expression of bcl-2 in Ulinastatin group was obviously higher than those in pseudoperation group and ischemia-reperfusion group at 6 h,12 h and 24 h of reperfusion(P0.05).The expression level of HSP70 in ischemia-reperfusion group and Ulinastatin group was higher than those in pseudoperation group at 12 h and 24 h of reperfusion(P0.05).Histopathologic observation:the inflammation was alleviated in the Ulinastatin group.Conclusion Ulinastatin may reduce the expression level of TNF-α and IL-1β during the pancreatic ischemia and reperfusion,and may enhance the expression level of bcl-2.Ulinastatin has protective effects against the ischemia-reperfusion injury of the rats pancreas.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the protective effect of Ulinastatin on ischemia-reperfusion injury of pancreas in rats and assess the possible mechanism.Methods Seventy-two SD rats were randomly divided into pseudoperation group,ischemia-reperfusion group and Ulinastatin group.During the pancreatic ischemia for 30 minutes and reperfusion in 0,6,12 and 24 hours,serum TNF-α and IL-1β were determined with enzyme linked immunosorbent assay(ELISA);expression of bcl-2,HSP70 in pancreas cells were studied with immunohistochemical methods and pancreas histopathology was observed,respectively.Results The expression level of TNF-α and IL-1β in ischemia-reperfusion group was obviously higher than those in pseudoperation group and Ulinastatin group(P0.05);The expression of bcl-2 in Ulinastatin group was obviously higher than those in pseudoperation group and ischemia-reperfusion group at 6 h,12 h and 24 h of reperfusion(P0.05).The expression level of HSP70 in ischemia-reperfusion group and Ulinastatin group was higher than those in pseudoperation group at 12 h and 24 h of reperfusion(P0.05).Histopathologic observation:the inflammation was alleviated in the Ulinastatin group.Conclusion Ulinastatin may reduce the expression level of TNF-α and IL-1β during the pancreatic ischemia and reperfusion,and may enhance the expression level of bcl-2.Ulinastatin has protective effects against the ischemia-reperfusion injury of the rats pancreas.
Key concepts: Ulinastatin, Medicine, Ischemia, Reperfusion injury, Pancreas, Anesthesia, Inflammation, Hsp70